Business
Valerio Therapeutics : Projet de fusion entre Valerio Therapeutics et sa filiale Valour Bio
Valerio Therapeutics : Projet de fusion entre Valerio Therapeutics et sa filiale Valour
About this update from Valerio Therapeutics
31 Oct 2025 17:36 CET Subscribe Issuer VALERIO THERAPEUTICS communique-presseprojetfusion31102025vtxfr.pdf Source VALERIO THERAPEUTICS Provider Euronext Company Name VALERIO THERAPEUTICS ISIN FR0010095596 Symbol ALVIO Market Euronext Growth
View stock analysis, news, and events for Valerio Therapeutics
More from Valerio Therapeutics
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platfo...
August 24, 2026
Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Ac...
August 17, 2026